Rhode Island 2025 Regular Session

Rhode Island House Bill H5463

Introduced
2/12/25  

Caption

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

Companion Bills

No companion bills found.

Similar Bills

LA HB2

Provides for Medicaid eligibility determination functions and Medicaid fraud detection and prevention (Items #14 and 15) (EG INCREASE GF EX See Note)

LA HB480

Provides relative to Medicaid fraud detection and prevention (RE INCREASE GF EX See Note)

LA HB5

Provides for Medicaid eligibility determination functions and Medicaid fraud detection and prevention (Items #14 and 15)

LA SB7

Provides relative to Medicaid eligibility determination functions and Medicaid fraud detection and prevention. (Item #14 and Item #15) (gov sig)

LA HB251

Requires DHH to institute Medicaid cost containment measures to the extent allowed by federal regulations (OR DECREASE GF EX See Note)

LA HB213

Provides for Medicaid eligibility determination functions and Medicaid fraud detection and prevention (EG INCREASE GF EX See Note)

LA HB170

Requires the Dept. of Health and Hospitals to institute Medicaid cost containment measures to the extent allowed by federal regulations (OR -$34,298,198 GF EX See Note)

LA HB4

Makes Medicaid eligibility for certain enrollees contingent upon premium payments (Item #16) (OR INCREASE SG RV See Note)